CLINICAL_TRIALS
research
· 2024-10-15
Clinical Trial Update: Nebulised Hypertonic Saline to Decrease Respiratory Exacerbations in Neuromuscular Disease or Neurodisability [NA]
Summary
Clinical trial status update for a study evaluating nebulised hypertonic saline to reduce respiratory exacerbations in neuromuscular disease or neurodisability;…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Imperial College London | Conditions: Neuromuscular Diseases, Neurodevelopmental Disorders | NA | Status: NOT_YET_RECRUITING